Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extended treatment trial aims to control stubborn nasal polyps

NCT ID NCT06914908

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study follows adults with chronic sinusitis and nasal polyps who previously tried lunsekimig in an earlier trial. Participants will receive lunsekimig for 52 weeks to check long-term safety and see if it continues to help control symptoms like congestion and smell loss. The main goal is to monitor side effects while tracking changes in sinus symptoms and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alamo ENT Associates- Site Number : 8400001

    RECRUITING

    San Antonio, Texas, 78258, United States

  • ENT Associates of Texas - McKinne- Site Number : 8400014

    RECRUITING

    McKinney, Texas, 75070, United States

  • Essential Medical Research- Site Number : 8400020

    RECRUITING

    Tulsa, Oklahoma, 74137, United States

  • Investigational Site Number : 0320001

    RECRUITING

    Buenos Aires, 1121, Argentina

  • Investigational Site Number : 0320002

    RECRUITING

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number : 0320003

    RECRUITING

    Mendoza, 5500, Argentina

  • Investigational Site Number : 0560001

    RECRUITING

    Leuven, 3000, Belgium

  • Investigational Site Number : 0560002

    RECRUITING

    Ghent, 9000, Belgium

  • Investigational Site Number : 1000001

    RECRUITING

    Sofia, 1612, Bulgaria

  • Investigational Site Number : 6160001

    RECRUITING

    Warsaw, Masovian Voivodeship, 00-909, Poland

  • Investigational Site Number : 6160002

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 30-033, Poland

  • Investigational Site Number : 6160003

    RECRUITING

    Katowice, Silesian Voivodeship, 40-611, Poland

  • Investigational Site Number : 6160004

    RECRUITING

    Poznan, Greater Poland Voivodeship, 60-693, Poland

  • Investigational Site Number : 6160007

    RECRUITING

    Wroclaw, Lower Silesian Voivodeship, 50-750, Poland

  • Investigational Site Number : 8260001

    RECRUITING

    Newcastle upon Tyne, NE7 7DN, United Kingdom

  • Investigational Site Number : 8260003

    RECRUITING

    Manchester, M13 9WL, United Kingdom

  • McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8400017

    RECRUITING

    Bellaire, Texas, 77401, United States

  • Modena Allergy + Asthma- Site Number : 8400005

    RECRUITING

    La Jolla, California, 92037, United States

  • Pharmaceutical Research & Consulting- Site Number : 8400004

    RECRUITING

    Dallas, Texas, 75231, United States

  • Treasure Valley Medical Research- Site Number : 8400002

    RECRUITING

    Boise, Idaho, 83706, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC RHINOSINUSITIS WITH NASAL POLYPS